Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.78B.
ENTERPRISE VALUE (EV)
$1.78B
Agios Pharmaceuticals, Inc.
Market Cap
$1.87B
Enterprise Value (EV)
$1.78B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Agios Pharmaceuticals, Inc. (AGIO) | $1.87B | $1.78B |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | $1.88B |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | $2.40B |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | $1.71B |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | $1.75B |
| Absci Corporation (ABSI)vs › | $1.95B | $1.85B |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | $2.15B |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | $1.40B |
| Azenta, Inc. (AZTA)vs › | $1.97B | $1.83B |
| AxoGen, Inc. (AXGN)vs › | $2.00B | $1.93B |
Market Cap
$1.87B
Total Debt
$0.00
Cash
$89.13M
Enterprise Value
$1.78B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
